Welcome to LookChem.com Sign In|Join Free

CAS

  • or

71989-26-9

Post Buying Request

71989-26-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • N-alpha-FMOC-Nepsilon-BOC-L-Lysine/ CAS: 71989-26-9/N-alpha-FMOC-Nepsilon-BOC-L-Lysine raw material/ high-quality

    Cas No: 71989-26-9

  • USD $ 1.0-2.0 / Kilogram

  • 25 Kilogram

  • 1 Metric Ton/Month

  • Hubei DiBo chemical co., LTD
  • Contact Supplier

71989-26-9 Usage

Description

N-alpha-FMOC-Nepsilon-BOC-L-Lysine, also known as Fmoc-Lys(Boc)-OH, is a protected amino acid derivative that plays a crucial role in the synthesis of various bioactive compounds and drug delivery systems. It is characterized by the presence of two protecting groups, the 9-fluorenylmethoxycarbonyl (Fmoc) group at the alpha-amino group and the tert-butyloxycarbonyl (Boc) group at the epsilon-amino group of the lysine side chain. These protecting groups ensure the selective deprotection and coupling of the amino acid during peptide synthesis, making it a versatile building block for the development of complex peptide-based structures.

Uses

Used in Pharmaceutical Industry:
N-alpha-FMOC-Nepsilon-BOC-L-Lysine is used as a key intermediate in the solid-phase synthesis of dimeric RGD peptide-paclitaxel conjugates, which serve as a model for integrin-targeted drug delivery. This targeted approach allows for the efficient delivery of therapeutic agents, such as paclitaxel, to cancer cells, minimizing side effects and improving treatment outcomes.
Used in Biomedical Research:
In the field of biomedical research, N-alpha-FMOC-Nepsilon-BOC-L-Lysine is utilized for the synthesis of DOTA-conjugated multivalent cyclic-RGD peptide dendrimers. These dendrimers are designed for tumor targeting and imaging applications, enabling the precise localization and visualization of cancerous tissues, which is essential for accurate diagnosis and treatment planning.
Used in Chemical Synthesis:
N-alpha-FMOC-Nepsilon-BOC-L-Lysine is employed as a starting material in the synthesis of various complex organic compounds, such as pentasubstituted dihydroimidazolylbutyl dihydroimidazol-3-ium salts. This is achieved through coupling with p-methylbenzhydrylamine (MBHA) resin, which allows for the formation of novel chemical entities with potential applications in various industries.
Used in Peptide Synthesis:
In the field of peptide synthesis, N-alpha-FMOC-Nepsilon-BOC-L-Lysine is used as a building block for the Fmoc-based synthesis of bis-naphthalene diimide, a threading intercalator. N-alpha-FMOC-Nepsilon-BOC-L-Lysine has potential applications in the development of new drugs and therapeutic agents, particularly in the area of nucleic acid targeting and manipulation.
Used in Analytical Chemistry:
N-alpha-FMOC-Nepsilon-BOC-L-Lysine is also used in the synthesis of ε-Boc-ε-(3,5-bis-trifluoromethyl-benzyl)-α-Fmoc-L-Lysine, which serves as a 19F NMR-based screening tool. This tool is valuable for the rapid and sensitive detection of specific molecular interactions and conformational changes, which can be crucial for understanding the mechanisms of action of new drug candidates and optimizing their design.

Check Digit Verification of cas no

The CAS Registry Mumber 71989-26-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,1,9,8 and 9 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 71989-26:
(7*7)+(6*1)+(5*9)+(4*8)+(3*9)+(2*2)+(1*6)=169
169 % 10 = 9
So 71989-26-9 is a valid CAS Registry Number.
InChI:InChI=1/C26H32N2O6/c1-26(2,3)34-24(31)27-15-9-8-14-22(23(29)30)28-25(32)33-16-21-19-12-6-4-10-17(19)18-11-5-7-13-20(18)21/h4-7,10-13,21-22H,8-9,14-16H2,1-3H3,(H,27,31)(H,28,32)(H,29,30)

71989-26-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (B3072)  Nε-(tert-Butoxycarbonyl)-Nα-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-lysine  >98.0%(HPLC)(T)

  • 71989-26-9

  • 5g

  • 345.00CNY

  • Detail
  • TCI America

  • (B3072)  Nε-(tert-Butoxycarbonyl)-Nα-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-lysine  >98.0%(HPLC)(T)

  • 71989-26-9

  • 25g

  • 990.00CNY

  • Detail
  • Aldrich

  • (47624)  Fmoc-Lys(Boc)-OH  ≥98.0% (HPLC)

  • 71989-26-9

  • 47624-1G-F

  • 334.62CNY

  • Detail
  • Aldrich

  • (47624)  Fmoc-Lys(Boc)-OH  ≥98.0% (HPLC)

  • 71989-26-9

  • 47624-10G-F

  • 604.89CNY

  • Detail
  • Aldrich

  • (47624)  Fmoc-Lys(Boc)-OH  ≥98.0% (HPLC)

  • 71989-26-9

  • 47624-25G-F

  • 1,076.40CNY

  • Detail
  • Aldrich

  • (47624)  Fmoc-Lys(Boc)-OH  ≥98.0% (HPLC)

  • 71989-26-9

  • 47624-100G-F

  • 3,005.73CNY

  • Detail

71989-26-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid

1.2 Other means of identification

Product number -
Other names N-Fmoc-N'-Boc-L-Lysine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:71989-26-9 SDS

71989-26-9Relevant articles and documents

Optimized syntheses of Fmoc azido amino acids for the preparation of azidopeptides

Pícha, Jan,Budě?ínsky, Milo?,Machá?ková, Kate?ina,Collinsová, Michaela,Jirá?ek, Ji?í

, p. 202 - 214 (2017/04/06)

The rise of CuI-catalyzed click chemistry has initiated an increased demand for azido and alkyne derivatives of amino acid as precursors for the synthesis of clicked peptides. However, the use of azido and alkyne amino acids in peptide chemistry is complicated by their high cost. For this reason, we investigated the possibility of the in-house preparation of a set of five Fmoc azido amino acids: β-azido l-alanine and d-alanine, γ-azido l-homoalanine, δ-azido l-ornithine and ω-azido l-lysine. We investigated several reaction pathways described in the literature, suggested several improvements and proposed several alternative routes for the synthesis of these compounds in high purity. Here, we demonstrate that multigram quantities of these Fmoc azido amino acids can be prepared within a week or two and at user-friendly costs. We also incorporated these azido amino acids into several model tripeptides, and we observed the formation of a new elimination product of the azido moiety upon conditions of prolonged couplings with 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate/DIPEA. We hope that our detailed synthetic protocols will inspire some peptide chemists to prepare these Fmoc azido acids in their laboratories and will assist them in avoiding the too extensive costs of azidopeptide syntheses. Experimental procedures and/or analytical data for compounds 3–5, 20, 25, 26, 30 and 43–47 are provided in the supporting information.

Caged xanthones: Potent inhibitors of global predominant MRSA USA300

Chaiyakunvat, Pongkorn,Anantachoke, Natthinee,Reutrakul, Vichai,Jiarpinitnun, Chutima

supporting information, p. 2980 - 2983 (2016/06/13)

Total of 22 caged xanthones were subjected to susceptibility testing of global epidemic MRSA USA300. Natural morellic acid showed the strongest potency (MIC of 12.5 μM). However, its potent toxicity diminishes MRSA therapeutic potential. We synthetically modified natural morellic acid to yield 13 derivatives (3a-3m). Synthetically modified 3b retained strong potency in MRSA growth inhibition, yet the toxicity was 20-fold less than natural morellic acid, permitting the possibility of using caged xanthones for MRSA therapeutic.

Tri-peptide cationic lipids for gene delivery

Zhao, Yinan,Zhang, Shubiao,Zhang, Yuan,Cui, Shaohui,Chen, Huiying,Zhi, Defu,Zhen, Yuhong,Zhang, Shufen,Huang, Leaf

, p. 119 - 126 (2015/02/19)

Several novel tri-peptide cationic lipids were designed and synthesized for delivering DNA and siRNA. They have tri-lysine and tri-ornithine as headgroups, a carbamate group as a linker and 12 and 14 carbon atom alkyl groups as tails. These tri-peptide cationic lipids were prepared into cationic liposomes for the study of the physicochemical properties and gene delivery. Their particle size, zeta potential and DNA-binding were characterized to show that they were suitable for gene transfection. Further results indicate that these lipids can transfer DNA and siRNA very efficiently into NCI-H460 and Hep-2 tumor cells. The selected lipid, CDO14, was able to deliver combined siRNAs against c-Myc and VEGF for silencing distinct oncogenic pathways in lung tumors of mice, with little in vitro and in vivo toxicity. This journal is

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 71989-26-9